Professor Bengt Winblad ger sin syn på Alzheimer - området.
Interview with Bengt Winblad
Interview with Bengt Winblad (BIOMARKAPD) - JPND Symposium 2019
Bengt Winblad, EAN 2019 – Ageing and dementia
Bengt Winblad, EAN 2020 – Emerging therapeutic targets for Alzheimer's disease
Bengt Winblad: Alzheimer´s Disease - Present and future Treatment Strategies
Bengt Winblad, EAN 2020 – Overview of the MOPEAD Project
AlzeCure´s Capital Markets Day with Professor Bengt Winblad at Karolinska Institute, May 17th, 2023
AE Conference 2010 - Bengt Winblad (Sweden): New treatments for people with dementia
Bengt Winblad, EAN 2020 – Swedish Geriatric Neurologist Perspective on COVID-19
Bengt Winblad, EAN 2020 – Targeting Beta-amyloid for the Treatment of Early Alzheimer's
What are the benefits of participating in JPND? An interview with Bengt Winblad
Bengt Winblad Lifetime Achievement Award to Dr Mary Sano
Bengt WINBLAD @ IAGG
Professor Bengt Winblad om AlzeCures projekt Alzstatin och läkemedel vid Alzheimers sjukdom.
Bengt WINBLAD: European Alzheimer Disease Consortium
Bengt WINBLAD: European Alzheimer Disease Consortium 2
Tau-targeted therapy landscape in Alzheimer’s disease
How society needs to be made ready to treat Alzheimer’s disease
